Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17773051 | 0.83 | HMGCR (0.39) | ALDH1A1TDP1PIK3CD | |
| SCHEMBL9385428 | 0.77 | TSHR (0.33) | TDP1 | |
| SCHEMBL24235498 | 0.76 | — | — | |
| SCHEMBL19729240 | 0.76 | ALDH1A1 (0.35) | ALDH1A1TDP1PIK3CD | |
| SCHEMBL24235603 | 0.75 | — | — | |
| SCHEMBL19729222 | 0.74 | PIK3CD (0.36) | ALDH1A1TDP1PIK3CD | |
| SCHEMBL20445398 | 0.69 | — | — | |
| SCHEMBL20608261 | 0.67 | ALDH1A1 (0.35) | ALDH1A1TDP1PIK3CD | |
| SCHEMBL20608260 | 0.67 | ALDH1A1 (0.35) | ALDH1A1TDP1PIK3CD | |
| SCHEMBL16750132 | 0.65 | TSHR (0.38) | ALDH1A1TDP1PIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230183253-A1 | NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY | RHODE ISLAND HOSPITAL | 2023-06-15 | — | — | US | disclosed |
| US-20170362238-A1 | NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY | RHODE ISLAND HOSPITAL | 2017-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170362238-A1 | NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY | POLRMT, NT5C3B, CHMP4B | ALDH1A1 3359/4885TDP1 536/4885PIK3CD 3121/4885 |
| US-20230183253-A1 | NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY | POLRMT, NT5C3B, CHMP4B | ALDH1A1 3359/4885TDP1 536/4885PIK3CD 3121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.